Late-Onset Neutropenia after Rituximab Treatment for Adult-Onset Nephrotic Syndrome
نویسندگان
چکیده
منابع مشابه
Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature.
Rituximab is a chimeric monoclonal antibody against CD20 that is used mainly for the treatment of CD20-positive lymphoma. Recently, its use has been expanded to include treatment of other nonmalignant diseases such as rheumatologic diseases and autoimmune cytopenia. Correlating with the increased use of rituximab has been an increased number of reports of its late adverse effects. One of these ...
متن کاملEarly onset neutropenia after rituximab in lupus nephritis.
E-mail: [email protected] References 1. SILVE C: Hereditary hypophosphatasia and hyperphosphatasia. Curr Opin Rheumatol 1994; 6: 3369. 2. GRAEPEL P, BENTLEY P, FRITZ H, MIYAMOTO M, SLATER SR: Reproduction toxicity studies with pamidronate. Arzneimittelforschungnn 1992; 42: 654-67. 3. BLACK AJ, TOPPING J, DURHAM B, FARQUHARSON RG, FRASER WD: A detailed assessment of alterations in bone turno...
متن کاملRituximab-Related Late-Onset Neutropenia in Patients with Rheumatic Diseases: Successful Re-Challenge of the Treatment
BACKGROUND We describe here 2 patients who developed late-onset neutropenia after Rituximab treatment. While this phenomenon is well described among patients suffering from hematological malignancies, such adverse effects are rare among patients with rheumatic diseases. CASE REPORT Two patients, the first with rheumatoid arthritis and the second with granulomatosis with polyangiitis, were tre...
متن کاملRituximab treatment for adult purpura nephritis with nephrotic syndrome.
The case of a 68-year-old woman with purpura nephritis associated with nephrotic syndrome is herein described. The patient's clinical course and the findings of a renal biopsy study revealed purpura nephritis. Following treatment with corticosteroids and intravenous cyclophosphamide accompanied by an angiotensin II type I receptor-blocker, an anti-platelet drug and an hydroxymethylglutaryl (HMG...
متن کاملThe Evidence-Based Approach to Adult-Onset Idiopathic Nephrotic Syndrome
Adult-onset nephrotic syndrome (NS) differs from its pediatric counterpart in several important ways. Most importantly, NS in adults is more etiologically heterogeneous compared to children, and thus treatment approaches rely heavily on the histological diagnosis provided by renal biopsy. The evidence-based approach to treatment of adult NS has been critically examined by the Kidney Disease Imp...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Case Reports in Nephrology
سال: 2019
ISSN: 2090-6641,2090-665X
DOI: 10.1155/2019/3580941